NO20020999L - Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer - Google Patents

Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer

Info

Publication number
NO20020999L
NO20020999L NO20020999A NO20020999A NO20020999L NO 20020999 L NO20020999 L NO 20020999L NO 20020999 A NO20020999 A NO 20020999A NO 20020999 A NO20020999 A NO 20020999A NO 20020999 L NO20020999 L NO 20020999L
Authority
NO
Norway
Prior art keywords
mesoprogestins
prevention
treatment
receptor modulators
progesterone receptor
Prior art date
Application number
NO20020999A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020999D0 (no
Inventor
Kristof Chwalisz
Walter Elger
Gerd Schubert
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20020999D0 publication Critical patent/NO20020999D0/no
Publication of NO20020999L publication Critical patent/NO20020999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20020999A 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer NO20020999L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38614199A 1999-08-31 1999-08-31
PCT/US2000/023770 WO2001015679A2 (en) 1999-08-31 2000-08-31 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders

Publications (2)

Publication Number Publication Date
NO20020999D0 NO20020999D0 (no) 2002-02-28
NO20020999L true NO20020999L (no) 2002-03-14

Family

ID=23524338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020999A NO20020999L (no) 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer

Country Status (34)

Country Link
EP (1) EP1229906B1 (sl)
JP (1) JP2003535029A (sl)
KR (3) KR100864547B1 (sl)
AR (1) AR025457A1 (sl)
AT (1) ATE375160T1 (sl)
AU (1) AU781840B2 (sl)
BG (1) BG65817B1 (sl)
BR (1) BR0014161A (sl)
CA (1) CA2382580C (sl)
CO (1) CO5200772A1 (sl)
CZ (1) CZ2002704A3 (sl)
DE (1) DE60036723T2 (sl)
DK (1) DK1229906T3 (sl)
EA (1) EA007854B1 (sl)
EE (1) EE05172B1 (sl)
ES (1) ES2295050T3 (sl)
HR (1) HRP20020267A2 (sl)
HU (1) HUP0202429A3 (sl)
IL (1) IL148416A0 (sl)
LT (1) LT5034B (sl)
LV (1) LV12941B (sl)
ME (1) MEP13808A (sl)
MX (1) MXPA02002191A (sl)
NO (1) NO20020999L (sl)
NZ (1) NZ517471A (sl)
PE (1) PE20010578A1 (sl)
PL (1) PL198790B1 (sl)
PT (1) PT1229906E (sl)
RO (1) RO122179B1 (sl)
RS (1) RS50283B (sl)
SI (1) SI20852B (sl)
SK (1) SK287192B6 (sl)
UA (1) UA78184C2 (sl)
WO (1) WO2001015679A2 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005539016A (ja) * 2002-08-02 2005-12-22 シエーリング アクチエンゲゼルシャフト 女性用受胎調節及びホルモン置換療法のための高められた抗ゴナドトロピン活性を有するプロゲステロン受容体モジュレーター
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
US20040097591A1 (en) * 2002-11-18 2004-05-20 Kristof Chwalisz Use of selective progesterone receptor modulators for the treatment of androgen deficiency
DE102007011105A1 (de) 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
CA2765847A1 (en) * 2009-06-17 2010-12-23 National University Corporation Kumamoto University Prophylactic and/or therapeutic agent for dysmenorrhea
US8399432B2 (en) * 2009-10-27 2013-03-19 Lipogen Ltd. Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633244A1 (de) 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
DE4332284C2 (de) 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
US5696127A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
HUT78117A (hu) * 1994-12-22 1999-11-29 Ligand Pharmaceuticals Incorporated Szteroid receptor modulátor kinolin- és kondenzált kinolinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
DK0806952T3 (da) 1995-02-02 2003-06-16 Schering Ag Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
DK0900234T3 (da) * 1996-05-01 2000-11-06 Us Gov Health & Human Serv 21-substituerede progesteronderivater anvendt som nye antigestagener
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP1144396A2 (en) * 1999-01-14 2001-10-17 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
CN1353717A (zh) * 1999-05-04 2002-06-12 莱加制药公司 四环黄体酮受体调节剂化合物及其方法

Also Published As

Publication number Publication date
SK2992002A3 (en) 2002-07-02
EE200200104A (et) 2003-04-15
CZ2002704A3 (cs) 2003-02-12
LT2002031A (en) 2003-02-25
HUP0202429A3 (en) 2004-04-28
KR20020027616A (ko) 2002-04-13
SI20852A (sl) 2002-10-31
KR100755109B1 (ko) 2007-09-04
KR100864547B1 (ko) 2008-10-20
EA007854B1 (ru) 2007-02-27
BG106442A (bg) 2002-09-30
AU6946600A (en) 2001-03-26
KR20080066095A (ko) 2008-07-15
RO122179B1 (ro) 2009-02-27
YU14002A (sh) 2006-01-16
WO2001015679A2 (en) 2001-03-08
NZ517471A (en) 2004-02-27
EP1229906B1 (en) 2007-10-10
EP1229906A2 (en) 2002-08-14
SI20852B (sl) 2009-06-30
CA2382580A1 (en) 2001-03-08
MXPA02002191A (es) 2002-09-30
BR0014161A (pt) 2002-05-21
AU781840B2 (en) 2005-06-16
CA2382580C (en) 2009-05-19
ES2295050T3 (es) 2008-04-16
PL353930A1 (en) 2003-12-15
DK1229906T3 (da) 2008-02-11
EA200200282A1 (ru) 2002-10-31
BG65817B1 (bg) 2010-01-29
LV12941B (en) 2003-06-20
JP2003535029A (ja) 2003-11-25
PE20010578A1 (es) 2001-06-04
LT5034B (lt) 2003-07-25
EE05172B1 (et) 2009-06-15
RS50283B (sr) 2009-09-08
DE60036723D1 (de) 2007-11-22
PL198790B1 (pl) 2008-07-31
IL148416A0 (en) 2002-09-12
HRP20020267A2 (en) 2004-04-30
KR20070058023A (ko) 2007-06-07
SK287192B6 (sk) 2010-02-08
HUP0202429A2 (en) 2002-10-28
AR025457A1 (es) 2002-11-27
CO5200772A1 (es) 2002-09-27
WO2001015679A3 (en) 2001-11-22
DE60036723T2 (de) 2008-07-17
NO20020999D0 (no) 2002-02-28
MEP13808A (en) 2010-06-10
PT1229906E (pt) 2008-01-18
UA78184C2 (en) 2007-03-15
ATE375160T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
NO20020912L (no) Bicykliske androgen- og progesteronreseptorer- modulatorforbindelser og fremgangsmåter
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20024478L (no) Hormonerstatningsterapi ved anvendelse av kombinasjon av konjugerte östrogener og medroksyprogesteronacetat
ATE293971T1 (de) Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten
NO20022925D0 (no) EP4 reseptor selektive agonister for behandling av osteoporose
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
NO20022974D0 (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
ATE293447T1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20020999L (no) Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO20014049D0 (no) Kontrollert frigjorings-formulering for behandling av COPD
NO971449D0 (no) Nye hormonelle medikamenter og anvendelse derav for korrigering av östrogen-mangel
DK1239862T3 (da) Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft
AU1962801A (en) Device for treatment of spider veins
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20023841D0 (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemethos menn
DE60032655D1 (de) Einrichtung zur Chirurgie der Hornhaut
NO20022142L (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application